7:33 am Regeneron Pharms announces FDA acceptance of EYLEa injection supplemental biologics license application for the treatment of macular edema following branch retinal vein occlusion
View todays social media effects on REGN
View the latest stocks trending across Twitter. Click to view dashboard
See who Regeneron is hiring next, click here to view
